1. Home
  2. GKOS vs UFPI Comparison

GKOS vs UFPI Comparison

Compare GKOS & UFPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • UFPI
  • Stock Information
  • Founded
  • GKOS 1998
  • UFPI 1955
  • Country
  • GKOS United States
  • UFPI United States
  • Employees
  • GKOS N/A
  • UFPI N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • UFPI Forest Products
  • Sector
  • GKOS Health Care
  • UFPI Basic Materials
  • Exchange
  • GKOS Nasdaq
  • UFPI Nasdaq
  • Market Cap
  • GKOS 5.4B
  • UFPI 6.0B
  • IPO Year
  • GKOS 2015
  • UFPI 1993
  • Fundamental
  • Price
  • GKOS $84.11
  • UFPI $90.30
  • Analyst Decision
  • GKOS Strong Buy
  • UFPI Strong Buy
  • Analyst Count
  • GKOS 13
  • UFPI 2
  • Target Price
  • GKOS $121.46
  • UFPI $145.00
  • AVG Volume (30 Days)
  • GKOS 864.7K
  • UFPI 368.7K
  • Earning Date
  • GKOS 11-03-2025
  • UFPI 10-27-2025
  • Dividend Yield
  • GKOS N/A
  • UFPI 1.55%
  • EPS Growth
  • GKOS N/A
  • UFPI N/A
  • EPS
  • GKOS N/A
  • UFPI 5.75
  • Revenue
  • GKOS $432,953,000.00
  • UFPI $6,542,277,000.00
  • Revenue This Year
  • GKOS $28.90
  • UFPI N/A
  • Revenue Next Year
  • GKOS $25.57
  • UFPI $4.18
  • P/E Ratio
  • GKOS N/A
  • UFPI $15.72
  • Revenue Growth
  • GKOS 26.70
  • UFPI N/A
  • 52 Week Low
  • GKOS $77.10
  • UFPI $90.21
  • 52 Week High
  • GKOS $163.71
  • UFPI $141.33
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 45.81
  • UFPI 32.93
  • Support Level
  • GKOS $79.02
  • UFPI $91.91
  • Resistance Level
  • GKOS $89.29
  • UFPI $94.39
  • Average True Range (ATR)
  • GKOS 3.19
  • UFPI 1.91
  • MACD
  • GKOS 0.54
  • UFPI -0.24
  • Stochastic Oscillator
  • GKOS 49.76
  • UFPI 0.00

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About UFPI UFP Industries Inc.

UFP Industries Inc is a supplier of lumber to the manufactured housing industry. Today UFP Industries is a multibillion-dollar holding company with subsidiaries around the globe that serve three markets: retail, packaging and construction. Its business segments consist of UFP Retail Solutions, UFP Packaging, UFP Construction, All other and Corporate.

Share on Social Networks: